[CALT] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[CALT] Calliditas Therapeutics AB (publ)
Announcement Date
28-Apr-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -4,994.40%
YoY- 9.43%
Quarter Report
CALT's Result
CALT's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 451,561 294,592 269,384 191,352 429,042 260,056 64,047 266.38%
PBT -14,256 -164,082 -70,660 -208,019 10,066 -15,958 -192,090 -82.25%
Tax 4,112 4,276 21,274 -20,494 13,747 -6,848 339 425.52%
NP -18,368 -168,357 -91,934 -187,525 -3,681 -9,110 -192,429 -79.02%
Tax Rate - - - - -136.57% - - -
Total Cost 469,929 462,949 361,318 378,877 432,723 269,166 256,476 49.57%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -4.07 -57.15 -34.13 -98.00 -0.86 -3.50 -300.45 -94.27%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.34 -3.14 -1.71 -3.49 -0.07 -0.34 -7.24 -86.91%
EPS Diluted -0.34 -3.14 -1.71 -3.49 -0.07 -0.34 -7.24 -86.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.